Pfizer, BioNTech file for EU approval of Covid-19 vaccine
Published: 05:04 PM, 1 December 2020
Germany’s BioNTech and its US partner Pfizer applied for EU regulatory approval for their Covid-19 vaccine, raising hopes that the first jabs could be administered in December.
In a statement on Tuesday, the two companies said that they had submitted an application to the European Medicines Agency on Monday “for Conditional Marketing Authorisation (CMA)” for their vaccine after tests showed it was 95 percent effective against the novel coronavirus.
If approved, the jab could potentially be rolled out “in Europe before the end of 2020”, the statement said.